[1]
J. Norum, J. A. Olsen, E. A. Wist, and P. E. Lønning, “Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectiveness analysis”, AO, vol. 46, no. 2, pp. 153–164, Jan. 2007.